A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/713 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C12Q 1/02 (2006.01) G01N 33/50 (2006.01) C12N 15/113 (2010.01) C07K 16/28 (2006.01)
Patent
CA 2680368
The present invention relates to a therapeutic agent for malignant mesothelioma comprising a substance which inhibits binding of CD26 to extracellular matrix such as an siRNA targeting CD26 cDNA or an anti-CD26 antibody. The present invention relates to a method of treating malignant mesothelioma, which comprises administering to a patient the substance.
La présente invention concerne un agent thérapeutique pour le mésothéliome malin comportant une substance inhibitrice de la liaison de CD26 à la matrice extracellulaire tel qu'un ADNc CD26 ciblant un ARNsi ou un anticorps anti-CD26. La présente invention concerne également un procédé de traitement de mésothéliome malin comprenant l'administration de la substance à un patient.
Inamoto Teruo
Morimoto Chikao
Ohnuma Kei
Smart & Biggar
The University Of Tokyo
LandOfFree
A method of treating malignant mesothelioma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A method of treating malignant mesothelioma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method of treating malignant mesothelioma will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1977996